AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2013
Jan 29, 2013
29745_dirs_2013-01-29_478aebf9-5b99-4e86-b75b-8ff446b44227.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2013-01-25
Reporting Person: Rice Derica W (EVP-Global Services and CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-01-25 | Common Stock | A | 53845 | $53.21 | Acquired | 53845 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-01-25 | Restricted Stock Unit | $ | A | 29781 | Acquired | 2014-02-01 | Common Stock (29781) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 6522 | Indirect |
| Common Stock | 1696 | Indirect |
| Common Stock | 168640 | Indirect |
Footnotes
F1: Reporting person disclaims beneficial ownership of these shares.
F2: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29